Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
27.03.2024 - SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat ...
Source: wallstreet-online.de